The present invention provides compounds of Formula (I): wherein the variables A, B, Ar, R1, R2, and R3 are as defined herein. The compounds of Formula (I) can function as corticotropin releasing factor (CRF) receptor antagonists and can be useful, for example, in the treatment of disorders characterized by abnormal levels of CRF such as anxiety and depression.
本发明提供了化合物的结构式(I):其中变量A、B、Ar、R1、R2和R3的定义如本文所述。结构式(I)的化合物可以作为促
肾上腺皮质激素释放因子(CRF)受体
拮抗剂发挥作用,并且可以用于治疗由CRF异常
水平引起的疾病,如焦虑和抑郁症。